Flawed WHO recommendations on hypertension: WHO has damaged its reputation.
(1) The international expert group ignored the ground rules governing clinical assessment, and clinical trial data too, taking up a stance that favours drug manufacturers.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016265:Conflict of Interest; D004232:Diuretics / Q000627:therapeutic use; D004345:Drug Industry; D006801:Humans; D006973:Hypertension / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014944:World Health Organization
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics